These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38957641)

  • 21. Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes.
    Gudjonsson JE; Karason A; Antonsdottir A; Runarsdottir EH; Hauksson VB; Upmanyu R; Gulcher J; Stefansson K; Valdimarsson H
    Br J Dermatol; 2003 Feb; 148(2):233-5. PubMed ID: 12588373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis.
    Chang YT; Tsai SF; Lee DD; Shiao YM; Huang CY; Liu HN; Wang WJ; Wong CK
    Br J Dermatol; 2003 Mar; 148(3):418-23. PubMed ID: 12653732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment.
    West J; Ogston S; Berg J; Palmer C; Fleming C; Kumar V; Foerster J
    Clin Exp Dermatol; 2017 Aug; 42(6):651-655. PubMed ID: 28512993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of IL12B risk haplotype and lack of interaction with HLA-Cw6 among the psoriasis patients in India.
    Chandra A; Senapati S; Ghosh S; Chatterjee G; Chatterjee R
    J Hum Genet; 2017 Mar; 62(3):389-395. PubMed ID: 27829679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-Cw6 Status and Treatment Responses Between Psoriasis Patients.
    Temel B; Adisen E; Gonen S
    Indian J Dermatol; 2021; 66(6):632-637. PubMed ID: 35283491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA risk haplotype Cw6,DR7,DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris.
    Ikäheimo I; Tiilikainen A; Karvonen J; Silvennoinen-Kassinen S
    Arch Dermatol Res; 1996 Jun; 288(7):363-5. PubMed ID: 8818183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine mapping of the psoriasis susceptibility gene PSORS1: a reassessment of risk associated with a putative risk haplotype lacking HLA-Cw6.
    Elder JT;
    J Invest Dermatol; 2005 May; 124(5):921-30. PubMed ID: 15854032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-Onset Versus Late-Onset Psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a Tertiary Care Center.
    Fatema F; Ghoshal L; Saha A; Agarwal S; Bandyopadhyay D
    Indian J Dermatol; 2021; 66(6):705. PubMed ID: 35283511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis.
    Tazi Ahnini R; Camp NJ; Cork MJ; Mee JB; Keohane SG; Duff GW; di Giovine FS
    Hum Mol Genet; 1999 Jun; 8(6):1135-40. PubMed ID: 10332047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical associations of the risk alleles of HLA-Cw6 and CCHCR1*WWCC in psoriasis.
    Suomela S; Kainu K; Onkamo P; Tiala I; Himberg J; Koskinen L; Snellman E; Karvonen SL; Karvonen J; Uurasmaa T; Reunala T; Kivikäs K; Jansén CT; Holopainen P; Elomaa O; Kere J; Saarialho-Kere U
    Acta Derm Venereol; 2007; 87(2):127-34. PubMed ID: 17340018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-C*12:02 is a susceptibility factor in late-onset type of psoriasis in Japanese.
    Mabuchi T; Ota T; Manabe Y; Ikoma N; Ozawa A; Terui T; Ikeda S; Inoko H; Oka A
    J Dermatol; 2014 Aug; 41(8):697-704. PubMed ID: 25099155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China.
    Jin Y; Yang S; Zhang F; Kong Y; Xiao F; Hou Y; Fan X; Zhang X
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):132-7. PubMed ID: 18702622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of MHC class I risk haplotypes in Thai and Caucasian psoriatics shows locus heterogeneity at PSORS1.
    Stuart PE; Nair RP; Hiremagalore R; Kullavanijaya P; Kullavanijaya P; Tejasvi T; Lim HW; Voorhees JJ; Elder JT
    Tissue Antigens; 2010 Nov; 76(5):387-97. PubMed ID: 20604894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between HLA-Cw1 and Systemic Treatment Response of Asian Psoriasis Patients.
    Ho SS; Tsai TF
    Mol Diagn Ther; 2022 Sep; 26(5):541-549. PubMed ID: 35789988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab.
    De Keyser E; Busard CI; Lanssens S; Meuleman L; Hutten BA; Costanzo A; van den Reek JM; Zweegers J; Lambert J; Spuls PI
    Ther Drug Monit; 2019 Oct; 41(5):634-639. PubMed ID: 31107404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of HLA antigens in the aetiology of psoriasis.
    Bahcetepe N; Kutlubay Z; Yilmaz E; Tuzun Y; Eren B
    Med Glas (Zenica); 2013 Aug; 10(2):339-42. PubMed ID: 23892855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis.
    Burlando M; Russo R; Clapasson A; Carmisciano L; Stecca A; Cozzani E; Parodi A
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32998429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis vulgaris.
    Ozawa A; Ohkido M; Inoko H; Ando A; Tsuji K
    J Invest Dermatol; 1988 Mar; 90(3):402-5. PubMed ID: 2894398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: relationship to age of onset (author's transl)].
    Mayr WR; Gschnait F; Brenner W
    Wien Klin Wochenschr; 1979 Mar; 91(5):164-6. PubMed ID: 425536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients.
    Batalla A; Coto E; González-Fernández D; González-Lara L; Gómez J; Santos-Juanes J; Queiro R; Coto-Segura P
    Pharmacogenet Genomics; 2015 Jun; 25(6):313-6. PubMed ID: 25794162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.